Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TANDKLINIKKEN FREDERIKSSUND ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   1.1% 1.0% 1.1% 1.3% 1.0% 1.4% 14.3% 14.3%   Credit score (0-100)   85 86 82 79 86 77 15 15   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   361.5 459.3 215.2 67.0 272.2 33.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   19,031 13,974 12,734 12,705 12,141 13,028 0.0 0.0   EBITDA   5,287 4,253 2,646 2,665 1,060 2,083 0.0 0.0   EBIT   5,149 4,159 2,597 2,620 995 2,016 0.0 0.0   Pre-tax profit (PTP)   5,256.0 4,232.0 2,648.0 2,660.0 1,029.0 2,007.3 0.0 0.0   Net earnings   4,098.0 3,301.0 2,063.0 2,076.0 803.0 1,565.9 0.0 0.0   Pre-tax profit without non-rec. items   5,256 4,232 2,648 2,660 1,029 2,007 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   189 95.0 77.0 138 250 184 0.0 0.0   Shareholders equity total   4,298 3,501 2,263 2,276 1,003 1,766 0.0 0.0   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,938 5,992 5,232 3,870 2,329 3,149 0.0 0.0   Net Debt   -995 -566 -806 -578 -678 -1,237 0.0 0.0     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   19,031 13,974 12,734 12,705 12,141 13,028 0.0 0.0   Gross profit growth   12.1% -26.6% -8.9% -0.2% -4.4% 7.3% -100.0% 0.0%   Employees   20 19 17 17 18 17 0 0   Employee growth %   0.0% -5.0% -10.5% 0.0% 5.9% -5.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,938 5,992 5,232 3,870 2,329 3,149 0 0   Balance sheet change%   17.5% -13.6% -12.7% -26.0% -39.8% 35.2% -100.0% 0.0%   Added value   5,287.0 4,253.0 2,646.0 2,665.0 1,040.0 2,082.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -193 -188 -67 16 47 -133 -184 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   27.1% 29.8% 20.4% 20.6% 8.2% 15.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   81.9% 65.5% 47.2% 58.9% 33.7% 74.2% 0.0% 0.0%   ROI %   140.1% 108.6% 92.0% 118.2% 63.8% 146.8% 0.0% 0.0%   ROE %   109.3% 84.7% 71.6% 91.5% 49.0% 113.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   61.9% 58.4% 43.3% 58.8% 43.1% 56.1% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -18.8% -13.3% -30.5% -21.7% -64.0% -59.4% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   2.5 2.3 1.7 2.2 1.4 2.0 0.0 0.0   Current Ratio   2.5 2.3 1.7 2.2 1.4 2.0 0.0 0.0   Cash and cash equivalent   995.0 566.0 806.0 578.0 678.0 1,236.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,934.0 3,231.0 2,005.0 1,957.0 572.0 1,401.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   264 224 156 157 58 123 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   264 224 156 157 59 123 0 0   EBIT / employee   257 219 153 154 55 119 0 0   Net earnings / employee   205 174 121 122 45 92 0 0